Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%

NCT02752646 is registered in ClinicalTrials.gov with MDbackline, LLC as lead sponsor.

NCT NCT02752646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02752646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Lead sponsor
MDbackline, LLC
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2016
Completion date
March 1, 2017
Enrollment
200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cataract